Transmedics
TMDX
134 hedge funds and large institutions have $720M invested in Transmedics in 2022 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 38 increasing their positions, 40 reducing their positions, and 6 closing their positions.
22,018% more call options, than puts
Call options by funds: $8.85M | Put options by funds: $40K
433% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 6
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
28% more capital invested
Capital invested by funds: $561M → $720M (+$158M)
22% more funds holding
Funds holding: 110 → 134 (+24)
7.14% more ownership
Funds ownership: 74.59% → 81.73% (+7.1%)
5% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 40
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$16.4M |
| 2 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$14.7M |
| 3 |
Millennium Management
New York
|
+$6.43M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$5.83M |
| 5 |
KLC
Kent Lake Capital
Reno,
Nevada
|
+$5.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$10.2M |
| 2 |
SCP
Sandhill Capital Partners
Buffalo,
New York
|
-$8.62M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$6.72M |
| 4 |
SAM
Silvercrest Asset Management
New York
|
-$3.46M |
| 5 |
MAP
Moody Aldrich Partners
Marblehead,
Massachusetts
|
-$2.17M |
TMDX Hedge Fund Activity: Q2 2022 in Review
134 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q2 2022, worth a combined $720M — up 28% from $561M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new TMDX positions and 6 closed out — a net gain of 26 holders — while 38 added to existing stakes and 40 trimmed.
The largest buyer was Driehaus Capital Management, opening a new position worth an estimated $16.4M. The largest seller was Portolan Capital Management, exiting entirely with an estimated $10.2M sold.
- 134 institutional investors held Transmedics (TMDX) as of Q2 2022, up from 110 in Q1 2022.
- Funds reported $720M of Transmedics stock for Q2 2022, up 28% quarter-over-quarter.
- 32 funds opened new Transmedics positions in Q2 2022 and 6 closed out, a net change of +26 holders.
- The largest Transmedics buyer in Q2 2022 was Driehaus Capital Management, an estimated $16.4M added.
- The largest Transmedics seller in Q2 2022 was Portolan Capital Management, an estimated $10.2M sold.
Based on aggregated 13F filings for Q2 2022.